Related Experiment Videos
Alpha-interferon and pregnancy in a patient with CML
J H Lipton1, C M Derzko, J Curtis
1Department of Medicine, Princess Margaret Hospital, Toronto, Ontario, Canada.
Hematological Oncology
|September 1, 1996
Summary
Chronic interferon therapy for chronic myeloid leukemia (CML) may not preclude conception. This case study shows a successful pregnancy and delivery in a woman undergoing infertility treatment while on interferon.
Area of Science:
- Reproductive Endocrinology
- Hematology
- Pharmacology
Background:
- Interferon therapy is a common treatment for chronic myeloid leukemia (CML).
- Fertility challenges can arise in women undergoing long-term medical treatments.
- The impact of interferon on female reproductive health requires further investigation.
Observation:
- A 34-year-old woman with a 7-year history of interferon treatment for CML presented with conception difficulties.
- Infertility evaluation identified a short luteal phase as a contributing factor.
- Clomiphene citrate therapy was initiated to address the luteal phase defect.
Findings:
- The patient successfully conceived following clomiphene citrate treatment.
- A healthy infant was delivered via Cesarean section.
- This suggests that interferon therapy may not be an absolute contraindication to pregnancy.
Implications:
- Women with CML on chronic interferon therapy may still achieve successful pregnancies with appropriate reproductive support.
- Further research is warranted to understand the mechanisms and optimize management of fertility in women on long-term interferon treatment.
- This case highlights the importance of comprehensive infertility evaluations in women with chronic medical conditions.